Published on March 10, 2010 at 9:00 PM
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the Integra™ Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The system provides an optimal balance of compression and stability by combining the Surfix® locking technology and dynamic compression.
The Integra™ Total Wrist Fusion System has received 510k clearance from the United States Food and Drug Administration (FDA) and will be featured at the American Academy of Orthopaedic Surgeons on March 9-13, in New Orleans, Louisiana.
"The Integra™ Total Wrist Fusion System is a significant addition to our family of upper extremity products," said Robert Paltridge, President of Integra Extremity Reconstruction. "It expands our portfolio of products that address severe wrist arthritis, which includes the Universal2™ Total Wrist Implant System, and gives surgeons another treatment option with unique benefits."
The Integra™ Total Wrist Fusion System will be sold by Integra's Extremity Reconstruction sales organization, which focuses on lower extremity reconstruction, upper extremity reconstruction, tendon protection/augmentation, peripheral nerve repair/protection, and wound repair.
Source Integra LifeSciences Holdings Corp